LOW-VOLUME · MALE-LED
terazosin Side Effects
terazosin (also sold as Hytrin) is a LOW-VOLUME FAERS extract #350 of 524 by FAERS report count. Still opens on MALE-LED: 15% of sex-coded reports are female (1,047 F / 5,875 M).
Data updated 2026-05-15
- 7,436
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
terazosin reporting skew - 15% of sex-coded reports are female (1,047 F / 5,875 M). Volume band LOW-VOLUME #350 of 524 by FAERS report count; caseload WATCHLIST.
Thinner FAERS extract for terazosin (Hytrin) (7,436 reports #350 of 524 by FAERS report count). 15% of sex-coded reports are female (1,047 F / 5,875 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2002–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
FATIGUE leads 466 of 7,436 reports
MALE-LED reporters · age peak 75+
Male-led reporters (85% of sex-coded rows)
Age peak 75+ (2,102 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (836 reports, 11.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 325 |
| ACUTE KIDNEY INJURY | 61 |
| PNEUMONIA | 61 |
| RENAL FAILURE | 57 |
| CHRONIC KIDNEY DISEASE | 55 |
| FALL | 46 |
| CARDIAC ARREST | 45 |
| DYSPNOEA | 45 |
| ASTHENIA | 38 |
| END STAGE RENAL DISEASE | 38 |
| COMPLETED SUICIDE | 34 |
| HYPOTENSION | 34 |
| MYOCARDIAL INFARCTION | 31 |
| DIARRHOEA | 29 |
| GASTROINTESTINAL HAEMORRHAGE | 29 |
| SEPSIS | 29 |
| CARDIAC FAILURE CONGESTIVE | 28 |
| FATIGUE | 28 |
| PLEURAL EFFUSION | 28 |
| CEREBROVASCULAR ACCIDENT | 27 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (2,657, 35.7% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FALL | 198 |
| PNEUMONIA | 192 |
| DYSPNOEA | 187 |
| ACUTE KIDNEY INJURY | 179 |
| ASTHENIA | 174 |
| HYPOTENSION | 157 |
| GASTROINTESTINAL HAEMORRHAGE | 149 |
| DIZZINESS | 148 |
| FATIGUE | 148 |
| RENAL FAILURE | 140 |
| DIARRHOEA | 127 |
| NAUSEA | 114 |
| ANAEMIA | 102 |
| HYPERTENSION | 99 |
| PAIN | 93 |
| PYREXIA | 93 |
| CEREBROVASCULAR ACCIDENT | 91 |
| SYNCOPE | 91 |
| ATRIAL FIBRILLATION | 90 |
How to read terazosin FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 7,436 voluntary reports linked to terazosin (Hytrin), 2002-2025. Death is listed on 836 (11.2%). Hospitalization appears on 2,657 (35.7%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and MALE-LED skew still differ by drug; not a complete safety profile.
Read with terazosin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 7,422 FAERS cases (Δ 14 lighter vs terazosin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 7,411 FAERS cases (Δ 25 lighter vs terazosin); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 7,404 FAERS cases (Δ 32 lighter vs terazosin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 7,398 FAERS cases (Δ 38 lighter vs terazosin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 50.9 pp vs terazosin's DEATH-HEAVY): CASELOAD · HOSP-MID.
terazosin stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.